Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trials
Authors
Jung‐Chun Lin (ORCID: https://orcid.org/0000-0001-5059-8766)
Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trials
Jung‐Chun Lin, Guan-Ju Chen, Tien‐Yu Huang, Chang-Hsien Liu et al.
Citations
4 citations
Journal
Journal of Translational Medicine
Topics
Liver Disease Diagnosis and Treatment
Field-Weighted Citation Impact (FWCI)
1.55
article
Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trials
Tri-Service General Hospital (TW), China Medical University (TW), National Tsing Hua University (TW), Taipei Medical University Hospital (TW), China Medical University Hospital (TW), Taipei Medical University (TW), National Defense Medical Center (TW)
Funders
National Applied Research Laboratories, Tri-Service General Hospital
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trials — Jung‐Chun Lin, Guan-Ju Chen, et al. · Journal of Translational Medicine (2024) | TGRS Research Map | TGRS